Bayer to pay $7.25 billion to settle Roundup non-Hodgkin lymphoma claims
FROM THE WIRE · FINANCE.YAHOO.COM
shutterstock.com / ZikG Agrochemical and biotech giant Bayer has agreed to pay $7.25 billion dollars to settle claims that its Roundup weedkiller causes non-Hodgkin lymphoma, a form of blood cancer. A Missouri judge Timothy Boyer approved the settlement on Nov. 20, determining…
Read at the source ↗MARKET IMPACTHIGH✦ News Impact agent estimateTone: expected bearishA settlement of this size over Roundup litigation weighs on Bayer's finances and outlook, a German mega-cap.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Bayer agreed to pay $7.25 billion to settle claims that its Roundup weedkiller causes non-Hodgkin lymphoma.
- 02A Missouri judge approved the settlement on Nov. 20, calling it fair, reasonable and adequate.
- 03The settlement will cover Roundup users already sick and those who become ill in the future.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets